3Hochberg MC.Updating the American Collage of Rheumatology revised criteria for the classification of systemic lupus erythematosus.Arthritis Rheum,1997,40:1725.
4ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature.The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes.Arthritis Rheum,1999,42:599-608.
5Bonbardier C,Gladman DD,Urowitz MB,et al.Derivation of the SLEDAI.A disease activity index for lupus patients.The Committee on Prognosis Studies in SLE.Arthritis Rheum,1992,35:630-640.
6Mok CC,Lau CS,Wong RWS.Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus.J Rheumatol,2001,28:766-771.
7Sanna G,Bertolaccini ML,Cuadrado MJ,et al.Neuropsychiatric manifestations in systemic lupus erythematosus:Prevalence and association with antiphospholipid antibodies.J Rheumatol,2003,30:985-992.
8Valesini G,Priori R,Francia A,et al.Central nervous system involvement in systemic lupus erythematosus:a new therapeutic approach with intrathecal dexamethasone and methotremate.Springer Semin Immunopathol,1994,16:313-321.
9Jennekens FG,Kater L.The central nervous system in systemic lupus erythematosus.Part 2.Pathogenetic mechanisms of clinical syndromes:a literature investigation.Rheumatology (Oxford),2002,41:619-630.
